KP

Kingsbrook Partners

North America, New York, United States, New York

Description

Kingsbrook Partners was added in 2010.

Investor Profile

Kingsbrook Partners has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kingsbrook Partners frequently co-invest with?

DC
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
Hartz Mountain Industries
North America, New Jersey, United States, Secaucus
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
Cowen Group
North America, New York, United States, New York
Co-Investments: 1
AC
North America, California, United States, San Francisco
Co-Investments: 1
SP
Europe, Midtjylland, Denmark, Holstebro
Co-Investments: 1

What are some of recent deals done by Kingsbrook Partners?

Cascadian Therapeutics

Seattle, Washington, United States

Cascadian Therapeutics is a bio-pharmaceutical company that researches, develops, and sells therapeutic products for treatment of cancer.

BiotechnologyHealth CareTherapeutics
Post Ipo EquitySep 24, 2010
Amount Raised: $14,900,000